Absence of Blood and Lymphatic Vessels in the Developing Human Cornea
- 1 July 2006
- journal article
- Published by Wolters Kluwer Health in Cornea
- Vol. 25 (6) , 722-726
- https://doi.org/10.1097/01.ico.0000214230.21238.3d
Abstract
The normal human cornea is devoid of both blood and lymphatic vessels and actively maintains this avascularity (corneal angiogenic privilege). Whether and when corneal angiogenic privilege is achieved during development is unknown. This study analyzed whether the cornea is primarily devoid of both blood and lymphatic vessels during intrauterine development or whether secondary regression of pre-existing vessels occurs before delivery. Indirect double immunohistochemistry was performed on 4-microm serial pupil-optic disc sections of paraffin-embedded human eyes stillborn at gestational ages of 17 to 41 weeks with antibodies against von Willebrand factor (vWF; factor VIII-associated antigen) as a panendothelial marker and with antibodies against lymphatic vessel endothelial hyaluronate receptor 1 (LYVE1) as a marker specific for lymphatic vascular endothelium. Human corneas were devoid of both vWF+++/LYVE-1(-) blood vessels and vWF+/LYVE-1+++ lymphatic vessels at all time-points analyzed. In contrast, there were numerous blood and lymphatic vessels detectable in the adjacent conjunctiva. The normal human cornea is primarily avascular and devoid of both blood and lymphatic vessels. Corneal angiogenic privilege is already achieved very early during fetal intrauterine development. This suggests early and strong expression of both antiangiogenic and antilymphangiogenic factors in the human cornea during development.Keywords
This publication has 18 references indexed in Scilit:
- Inhibition of Hemangiogenesis and LymphangiogenesisafterNormal-Risk Corneal Transplantation by Neutralizing VEGF Promotes Graft SurvivalInvestigative Opthalmology & Visual Science, 2004
- Roles of Thrombospondin-1 and -2 in Regulating Corneal and Iris AngiogenesisInvestigative Opthalmology & Visual Science, 2004
- New thoughts on the immunology of corneal transplantationEye, 2003
- Ocular immune privilege: therapeutic opportunities from an experiment of natureNature Reviews Immunology, 2003
- Corneal LymphangiogenesisCornea, 2003
- Draining Lymph Nodes of Corneal Transplant Hosts Exhibit Evidence for Donor Major Histocompatibility Complex (MHC) Class II–positive Dendritic Cells Derived from MHC Class II–negative GraftsThe Journal of Experimental Medicine, 2002
- Isolation and Characterization of Dermal Lymphatic and Blood Endothelial Cells Reveal Stable and Functionally Specialized Cell LineagesThe Journal of Experimental Medicine, 2001
- Corneal neovascularizationCurrent Opinion in Opthalmology, 2001
- THE IMMUNE PRIVILEGE OF CORNEAL ALLOGRAFTS1Transplantation, 1999
- LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for HyaluronanThe Journal of cell biology, 1999